Table 1.

Demographic parameters and surgical characteristics

Patient	Age (years)/ Gender	ASA	Primary Disease/Organ	PCI	CRS Excision	HIPEC drugs	HIPEC Duration	Blood Loss (ml)	Urine Output (ml)	Fluids (ml)	Duration of Surgery (min)	Vasopressor support at end of surgery (µg/kg/min)
Patient 1	69/M	II (IHD)	Appendix	20	Total Peritonectomy + greater and lesser omentectomy + small Bowel resection anastomosis + Retroperitoneal deposit excision + bilateral Diaphragmatic peritonectomy + Cholecystectomy + Port site excision)	Mitomycin + Doxorubicin 15 mg/m2	60	2000	1500	RL 4500 Albumin 4% 1500 PRBC 256	675	0
Patient 2	35/F	II (Current Hypothyroidism)	Krukenberg’s tumour secondary to metastatic adenocarcinoma of colon	7	Anterolateral parietal peritonectomy, pelvic peritonectomy, TAH, BSO, Redo low anterior resection, Small bowel RA, Omentectomy, Hartmann colostomy.	Mitomycin + Doxorubicin 15 mg/m2	90	3400	1750	RL 6000 Albumin 4% 500 Gelofusine 500 PRBC 765	675	0
Patient 3	45/F	I	Appendix	34	Total peritonectomy + anterior resection + limited right hemicolecomy + splenectomy + omentectomy + cholecystectomy + falciform ligament excision + glisson capsule excision	Mitomycin + Doxorubicin 15 mg/m2	90	3200	1900	RL 10000 Gelofusine 2500 Albumin4% 1000 PRBC 760 FFP 410	780	0.2
Patient 4	49/F	I	Adnexal mass with pseudomyxoma peritonei	10	Total parietal peritonectomy + Omentectomy (Operated for CRS-HIPEC in 2019)	Mitomycin + Doxorubicin 15 mg/m2	60	3500	2100	RL 7000 Albumin 4% 1500 PRBC 780 FFP 650	585	0

ASA: American Society of Anesthesiologists; CRS: Cytoreductive Surgery; FFP: Fresh Frozen Plasma; HIPEC: Hyperthermic Intraperitoneal Chemotherapy; PRBC: Packed Red Blood Cells; PCI: Peritoneal Carcinomatosis Index; RL: Ringer Lactate; TAH-BSO: Total Abdominal Hysterectomy-Bilateral Salpingooophorectomy; M-male; F-female; IHD- Ischaemic heart disease, RA: Resection-anastomosis